(Q40939808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

review article

1 reference

title

Quinolone activity against anaerobes: microbiological aspects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

0 references

P C Appelbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

49 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

76-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549420%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199500492-00012

14 October 2019

exact match

0 references

cites work

Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin

1 reference

12 December 2020

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

1 reference

12 December 2020

Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres

1 reference

12 December 2020

Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole

1 reference

12 December 2020

Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U

1 reference

12 December 2020

Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions

1 reference

12 December 2020

In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents

1 reference

12 December 2020

In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study

1 reference

12 December 2020

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

1 reference

12 December 2020

Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone

1 reference

12 December 2020

Reduction of oral flora with ciprofloxacin in healthy volunteers

1 reference

12 December 2020

Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria

1 reference

12 December 2020

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

1 reference

12 December 2020

In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone

1 reference

12 December 2020

Mechanisms of beta-lactam resistance in anaerobic bacteria.

1 reference

12 December 2020

In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.

1 reference

12 December 2020

Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent

1 reference

12 December 2020

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

1 reference

12 December 2020

In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones

1 reference

12 December 2020

Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses

1 reference

12 December 2020

Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin

1 reference

12 December 2020

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam

1 reference

12 December 2020

Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria

1 reference

12 December 2020

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)

1 reference

12 December 2020

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

12 December 2020

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents

1 reference

12 December 2020

In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria

1 reference

12 December 2020

In vitro activities of three of the newer quinolones against anaerobic bacteria

1 reference

12 December 2020

Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.

1 reference

12 December 2020

Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

12 December 2020

The killing action of fleroxacin upon Bacteroides fragilis

1 reference

12 December 2020